Indivior Pharmaceuticals, Inc. (INDV)

34.77 +0.90 (+2.66%) USD  |  NASDAQ  |  Oct 20, 16:00
35.09 +0.32 (+0.92%) After-Hours: 07:27
More

Indivior Pharmaceuticals Gross Profit (TTM) : 1.116B for June 30, 2026

Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 1.116B
March 31, 2026 1.073B
December 31, 2025 1.018B
September 30, 2025 974.00M
June 30, 2025 963.00M
March 31, 2025 933.00M
December 31, 2024 957.00M
September 30, 2024 946.00M
June 30, 2024 924.00M
March 31, 2024 927.00M
December 31, 2023 891.00M
September 30, 2023 847.00M
June 30, 2023 816.00M
March 31, 2023 772.00M
December 31, 2022 729.00M
September 30, 2022 715.00M
June 30, 2022 684.00M
March 31, 2022 671.00M
December 31, 2021 649.00M
September 30, 2021 621.00M
June 30, 2021 592.00M
March 31, 2021 553.00M
December 31, 2020 539.00M
Date Value
September 30, 2020 471.00M
June 30, 2020 503.00M
March 31, 2020 561.00M
December 31, 2019 627.00M
September 30, 2019 739.00M
June 30, 2019 786.00M
March 31, 2019 831.00M
December 31, 2018 862.00M
September 30, 2018 894.00M
June 30, 2018 930.00M
March 31, 2018 961.00M
December 31, 2017 977.00M
September 30, 2017 976.00M
June 30, 2017 975.00M
March 31, 2017 949.00M
December 31, 2016 936.00M
September 30, 2016 917.00M
June 30, 2016 894.00M
March 31, 2016 895.00M
December 31, 2015 885.00M
September 30, 2015 676.00M
June 30, 2015 457.00M
March 31, 2015 221.00M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Supernus Pharmaceuticals, Inc. 629.69M
Eli Lilly & Co. 66.44B
Bristol Myers Squibb Co. 32.78B
Liquidia Corp. 416.18M
Harmony Biosciences Holdings, Inc. 700.15M